GlassScriptPhysician profile
Robert Todd Snowden
NPI 1376545152
$1,719.16
in general payments reported to CMS, 2019-2025
16 companies · $734 in 2025
The $734 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.57 · 2020: $140 · 2021: $68.61 · 2022: $435 · 2023: $70.90 · 2024: $190 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903 · Education: $91.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.43 |
| Education | $91.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $386.09 | 2022 | |
| Genzyme Corporation | $354.62 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $233.05 | 2020-2025 | Dupixent |
| Glaxosmithkline, LLC. | $213.56 | 2023-2025 | Nucala |
| Aerin Medical INC. | $206.58 | 2020-2025 | |
| Optinose US, INC. | $105.95 | 2019-2024 | |
| Medtronic, INC. | $42.81 | 2025 | |
| Davol INC. | $42.23 | 2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $19.85 | 2025 | Tezspire |
| Smith+Nephew, INC. | $15.26 | 2020 | |
| Ambu INC. | $14.49 | 2020 | |
| Phathom Pharmaceuticals, INC. | $13.42 | 2024 | Voquezna |
| Stryker Corporation | $12.86 | 2023 | Fiagon Navigation Unit |
| Intersect Ent, INC. | $12.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $12.06 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Snowden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.